Groot Fedde, Kuijpers Taco W, Berkhout Ben, de Jong Esther C
Department of Cell Biology and Histology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Retrovirology. 2006 Nov 1;3:75. doi: 10.1186/1742-4690-3-75.
Dendritic cells (DC) have been proposed to mediate sexual HIV-1 transmission by capturing the virus in the mucosa and subsequently presenting it to CD4+ T cells. We have demonstrated before that DC subsets expressing higher levels of intercellular adhesion molecule-1 (ICAM-1) are better HIV-1 transmitters. ICAM-1 binds leukocyte function-associated molecule-1 (LFA-1) on T cells, an integrin responsible for adhesion and signaling at the immunological synapse. To corroborate the importance of the ICAM-1- LFA-1 interaction, we performed transmission experiments to LFA-1 negative leukocytes from Leukocyte Adhesion Deficiency type 1 (LAD-1) patients.
We clearly show that DC-mediated HIV-1 transmission to LAD-1 T cells is impaired in comparison to healthy controls. Furthermore, HIV-1 transmission to T cells from a unique LAD-1 patient with a well characterized LFA-1 activation defect was impaired as well, demonstrating that activation of LFA-1 is crucial for efficient transmission. Decreased cell adhesion between DC and LAD-1 T cells could also be illustrated by significantly smaller DC-T cell clusters after HIV-1 transmission.
By making use of LFA-1 defect cells from unique patients, this study provides more insight into the mechanism of HIV-1 transmission by DC. This may offer new treatment options to reduce sexual transmission of HIV-1.
树突状细胞(DC)被认为可通过在黏膜中捕获病毒并随后将其呈递给CD4+T细胞来介导HIV-1的性传播。我们之前已经证明,表达较高水平细胞间黏附分子-1(ICAM-1)的DC亚群是更好的HIV-1传播者。ICAM-1与T细胞上的白细胞功能相关分子-1(LFA-1)结合,LFA-1是一种整合素,负责免疫突触处的黏附和信号传导。为了证实ICAM-1-LFA-1相互作用的重要性,我们对1型白细胞黏附缺陷症(LAD-1)患者的LFA-1阴性白细胞进行了传播实验。
我们清楚地表明,与健康对照相比,DC介导的HIV-1向LAD-1 T细胞的传播受损。此外,HIV-1向一名具有特征明确的LFA-1激活缺陷的独特LAD-1患者的T细胞的传播也受损,这表明LFA-1的激活对于有效传播至关重要。HIV-1传播后,DC与LAD-1 T细胞之间细胞黏附的减少也可通过明显更小的DC-T细胞簇来说明。
通过利用独特患者的LFA-1缺陷细胞,本研究对DC介导的HIV-1传播机制有了更多了解。这可能为减少HIV-1的性传播提供新的治疗选择。